IFAM
TGTX icon

Institutional & Family Asset Management’s TG Therapeutics TGTX Stock Holding History

Institutional & Family Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11
Closed – – 776
2022
Q2 		$0 Hold
11
– – ﹤0.01% 792
2022
Q1 		$0 Buy
11
+1
+10% +$12 ﹤0.01% 838
2021
Q4 		$0 Hold
10
– – ﹤0.01% 922
2021
Q3 		$0 Sell
10
-35
-78% -$1.08K ﹤0.01% 972
2021
Q2 		$2K Hold
45
– – ﹤0.01% 843
2021
Q1 		$2K Sell
45
-26
-37% -$1.25K ﹤0.01% 820
2020
Q4 		$4K Buy
71
+23
+48% +$777 ﹤0.01% 680
2020
Q3 		$1K Hold
48
– – ﹤0.01% 812
2020
Q2 		$1K Buy
+48
New +$773 ﹤0.01% 808

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Institutional & Family Asset Management's TGTX Position: Q3 2022 in Review

Institutional & Family Asset Management sold out of TG Therapeutics (TGTX) in Q3 2022, closing a stake of 11 shares.

Institutional & Family Asset Management first reported a position in TGTX in Q2 2020 and held it in 9 quarters. The position peaked at $4K in Q4 2020. 183 funds tracked by Wall St. Rank hold TGTX as of Q3 2022.

  • Institutional & Family Asset Management reported no remaining TG Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Institutional & Family Asset Management sold 11 TG Therapeutics shares in Q3 2022.
  • Institutional & Family Asset Management first reported a position in TG Therapeutics in Q2 2020 and held it in 9 quarters.
  • Institutional & Family Asset Management's TG Therapeutics position peaked at $4K in Q4 2020.
  • 183 funds tracked by Wall St. Rank held TG Therapeutics as of Q3 2022.

Based on Institutional & Family Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.